Non-myeloablative allogeneic hematopoietic stem cell transplantation.
Shelburne N, Bevans M.
Semin Oncol Nurs. 2009 May;25(2):120-8. doi: 10.1016/j.soncn.2009.03.006.
Autologous stem-cell transplantation and purging.
Löwenberg B, Voogt P.
J Clin Oncol. 1996 Aug;14(8):2194-6. doi: 10.1200/JCO.1996.14.8.2194.
Stem cell isolation.
Shpall EJ, Gee A, Cagnoni PJ, Hogan C, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB.
Curr Opin Hematol. 1995 Nov;2(6):452-9. doi: 10.1097/00062752-199502060-00009.
Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
Pettengell R.
Bone Marrow Transplant. 2002 Feb;29 Suppl 1:S1-4. doi: 10.1038/sj.bmt.1703294.
Rituximab: enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma.
Gisselbrecht C, Mounier N.
Semin Oncol. 2003 Feb;30(1 Suppl 2):28-33. doi: 10.1053/sonc.2003.50022.
[Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Endo M, Tanosaki R.
Gan To Kagaku Ryoho. 1995 Oct;22(12):1762-70.
Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcome.
Gianni AM, Berinstein NL, Evans PA, López-Guillermo A, Solano C.
Anticancer Drugs. 2002 Nov;13 Suppl 2:S35-42. doi: 10.1097/00001813-200211002-00006.
Overview of autologous stem cell transplantation.
Saba N, Abraham R, Keating A.
Crit Rev Oncol Hematol. 2000 Oct;36(1):27-48. doi: 10.1016/s1040-8428(00)00087-1.
Should we purge?
Bensinger WI.
Bone Marrow Transplant. 1998 Jan;21(2):113-5. doi: 10.1038/sj.bmt.1701051.
Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?
Sweetenham JW.
Bone Marrow Transplant. 2001 Nov;28(9):813-20. doi: 10.1038/sj.bmt.1703255.
